New PerkinElmer SARS-CoV-2 test kit for variants launched for research use
AlexSava/E+ via Getty Images
- PerkinElmer (NYSE:PKI) has launched its NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 for research use which makes it faster and easier to detect virus variants.
- With positive SARS-CoV-2 samples, the kit detects mutations associated with all SARS-CoV-2 variants, including Omicron.
- PerkinElmer says that NEXTFLEX v2 reduces turnaround time by an average of three hours.
- The kit is intended for use by large laboratories.
- PerkinElmer has previously said its COVID-19 PCR tests are not impacted by the Omnicom variant.